v3.26.1
Commitments and Contingencies - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended
May 01, 2026
Oct. 22, 2025
USD ($)
Oct. 09, 2025
USD ($)
May 31, 2022
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Apr. 30, 2024
ft²
Apr. 01, 2024
ft²
Mar. 20, 2023
Commitments and Contingencies [Line Items]                      
Lease space | ft²                 24,866 23,696  
Lessee operating lease, lease commencement date             Mar. 20, 2023        
Operating lease, term of lease                     124 months
Operating lease, lease not yet commenced, option to extend             We also have one option to extend the Lease Term for five        
Operating lease, lease not yet commenced, existence of option to extend       true              
Operating lease, lease not yet commenced, extension term       5 years              
Base rent per square foot       $ 5.75              
Annual upward adjustments on base rate, percentage       3.00%              
Operating lease expense         $ 400,000 $ 400,000 $ 800,000 $ 800,000      
Operating lease, weighted average remaining lease term         7 years 1 month 6 days   7 years 1 month 6 days        
Operating lease, weighted average discount rate         8.80%   8.80%        
Financing lease, term of contract         48 months   48 months        
Financing lease, weighted-average remaining lease term         9 months 18 days   9 months 18 days        
Financing lease, weighted-average discount rate         8.40%   8.40%        
Motion to dismiss deadline date Aug. 28, 2026                    
Opposition response due date Sep. 28, 2026                    
Pending Litigation [Member]                      
Commitments and Contingencies [Line Items]                      
Loss contingency, lawsuit filing date   Oct. 22, 2025 Oct. 09, 2025                
Loss contingency, name of plaintiff   putative securities class action putative securities class action                
Loss Contingency, Name of Defendant   aTyr Pharma, Inc. and our Chief Executive Officer, Sanjay Shukla. aTyr Pharma, Inc. and our Chief Executive Officer, Sanjay Shukla.                
Estimated litigation liabillity   $ 0 $ 0                
Restricted Cash [Member]                      
Commitments and Contingencies [Line Items]                      
Security deposit         $ 700,000   $ 700,000        
Leased Equipment [Member] | Restricted Cash [Member]                      
Commitments and Contingencies [Line Items]                      
Security deposit         $ 800,000   $ 800,000